We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

38 hedge funds and large institutions have $76.6M invested in Fibrocell Science Inc. in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

14% less funds holding

Funds holding: 4438 (-6)

28% less capital invested

Capital invested by funds: $107M → $76.6M (-$30.3M)

33% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 12

60% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 10

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2K

Holders
38
Holders Change
-6
Holders Change %
-13.64%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
4
Increased
8
Reduced
12
Closed
10
Calls
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$60K
Name Holding Trade Value Shares
Change
Change in
Stake
TS
1
Third Security
Virginia
$45.4M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$10.5M
Jennison Associates
3
Jennison Associates
New York
$8.02M +$7.91K +169 +0.1%
MP
4
MSD Partners
New York
$5.01M
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.61M +$29.1K +621 +2%
CCA
6
Catalyst Capital Advisors
New York
$1.31M +$233K +4,967 +20%
Cambridge Investment Research Advisors
7
Cambridge Investment Research Advisors
Iowa
$601K +$647K +13,821 New
HVC
8
Healthcare Value Capital
New Jersey
$458K
Geode Capital Management
9
Geode Capital Management
Massachusetts
$445K +$92.6K +1,978 +24%
BCM
10
Bridgeway Capital Management
Texas
$379K
TMC
11
Trellus Management Company
Florida
$359K +$42.1K +900 +12%
Citigroup
12
Citigroup
New York
$301K -$41.2K -879 -11%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$287K
California Public Employees Retirement System
14
California Public Employees Retirement System
California
$276K
FSA
15
Franklin Street Advisors
North Carolina
$268K -$5.34K -114 -2%
Goldman Sachs
16
Goldman Sachs
New York
$218K +$40.4K +862 +21%
Northern Trust
17
Northern Trust
Illinois
$216K -$354K -7,551 -60%
SC
18
Saiers Capital
New York
$205K
BFA
19
BlackRock Fund Advisors
California
$194K -$15.1K -323 -7%
Morgan Stanley
20
Morgan Stanley
New York
$138K +$25K +534 +20%
SIP
21
Stoneridge Investment Partners
Pennsylvania
$136K +$53.3K +1,138 +57%
BIT
22
BlackRock Institutional Trust
California
$93K +$100K +2,142 New
Janney Montgomery Scott
23
Janney Montgomery Scott
Pennsylvania
$53.2K -$7.82K -167 -12%
EEG
24
E.E. Geduld
$44K
BGA
25
Belmont Global Advisors
Texas
$43K -$780K -16,667 -94%

FCSC Hedge Fund Activity: Q3 2014 in Review

38 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q3 2014, worth a combined $76.6M — down 28% from $107M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of FCSC and 4 opened new positions — a net loss of 6 holders — while 12 trimmed existing stakes and 8 added.

The largest buyer was Cambridge Investment Research Advisors, opening a new position worth an estimated $647K. The largest seller was Belmont Global Advisors, cutting an estimated $780K.

  • 38 institutional investors held Fibrocell Science Inc. (FCSC) as of Q3 2014, down from 44 in Q2 2014.
  • Funds reported $76.6M of Fibrocell Science Inc. stock for Q3 2014, down 28% quarter-over-quarter.
  • 4 funds opened new Fibrocell Science Inc. positions in Q3 2014 and 10 closed out, a net change of -6 holders.
  • The largest Fibrocell Science Inc. buyer in Q3 2014 was Cambridge Investment Research Advisors, an estimated $647K added.
  • The largest Fibrocell Science Inc. seller in Q3 2014 was Belmont Global Advisors, an estimated $780K sold.

Based on aggregated 13F filings for Q3 2014.